Resveratrol inhibits the progression of oral squamouscell carcinoma through Norad/Igf2bp2/Pdk1 pathway and remodeling glucose metabolism reprogramming
Resveratrol inhibits OSCC proliferation, particularly in CAL-27 cells. It affects NORAD, IGF2BP2, and PDK1 pathways, altering cell cycle protein expression and causing S and G2/M phase arrest.
Authors
- Yicong Lin (ORCID: https://orcid.org/0000-0002-3994-4637)
- Rongrong Zhang (ORCID: https://orcid.org/0009-0007-9427-3729)
- Jinjing Guo
Institutions
- Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1007/s12672-025-02363-z
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94